SEC 13F Intelligence

Managers / Q2 2025 · view latest →

Sivik Global Healthcare LLC

CIK 0001596452 · 133 TACONIC RD, GREENWICH, CT, 06831 · 203-769-8600

Reported Value
$368M
Q2 2025
Positions
46
Filings on Record
30
2019–present window
Filed
Jul 25, 2025
original filing

Summary

Sivik Global Healthcare LLC reported $368M in U.S.-listed holdings across 46 positions for Q2 2025.

Its largest position, XBI, represents 5.6% of the portfolio.

Compared with Q1 2025, the fund opened 18 new positions and exited 3.

Portfolio Metrics

Turnover
+5.8%
vs prior filed quarter
Top-10 Concentration
+28.4%
share of reported value
Largest Position
+5.6%
Spdr S P Biotech Etf
New / Exited
18 / 3
positions this quarter

Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded, with multiple share classes and repeated sub-manager rows for the same issuer combined into one position — the same rule the holdings table uses by default. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.

Reported Value by Quarter

13F Reported Value
Q4 ’18: $186MQ4 ’18Q1 ’19: $271MQ2 ’19: $414MQ3 ’19: $198MQ4 ’19: $269MQ4 ’19Q1 ’20: $253MQ2 ’20: $302MQ3 ’20: $232MQ4 ’20: $245MQ4 ’20Q1 ’21: $274MQ2 ’21: $512MQ3 ’21: $419MQ4 ’21: $233MQ4 ’21Q1 ’22: $242MQ2 ’22: $176MQ3 ’22: $180MQ4 ’22: $213MQ4 ’22Q1 ’23: $233MQ2 ’23: $428MQ3 ’23: $198MQ4 ’23: $239MQ4 ’23Q1 ’24: $427MQ2 ’24: $278MQ3 ’24: $236MQ4 ’24: $190MQ4 ’24Q1 ’25: $185MQ2 ’25: $368MQ3 ’25: $344MQ4 ’25: $345MQ4 ’25Q1 ’26: $132Mfilingsflow.com

Portfolio Composition

By security type
Common Stock: 51.8%Other: 39.2%ETP: 5.6%ADR: 3.4%
  • Common Stock · 51.8% · $190M
  • Other · 39.2% · $144M
  • ETP · 5.6% · $21M
  • ADR · 3.4% · $13M

Quarter-over-Quarter Changes full breakdown →

vs Q1 2025 (amended baseline)

IssuerMoveShare ΔShares nowValue ΔValue now
PUT - SPY 100 @ 599 EXP 07/18/2025NEW+400400+$24M$24M
PUT - SPY 100 @ 596 EXP 07/18/2025NEW+400400+$24M$24M
PUT - SPY 100 @ 602 EXP 07/31/2025NEW+300300+$18M$18M
PUT - SPY 100 @ 597 EXP 07/18/2025NEW+300300+$18M$18M
PUT - SPY 100 @ 610 EXP 08/15/2025NEW+250250+$15M$15M
PUT - SPY 100 @ 607 EXP 07/31/2025NEW+250250+$15M$15M
PUT - SPY 100 @ 600 EXP 08/15/2025NEW+250250+$15M$15M
PUT - SPY 100 @ 593 EXP 07/31/2025NEW+250250+$15M$15M

Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.

Holdings — Q2 2025

38 positions
Export to Excel
#IssuerClass% PortfolioValue ↓Shares
1XBISPDR S&P BIOTECH ETFhistory →S&P BIOTECH5.64%$21M250.0K
2THCTENET HEALTHCAREhistory →COM NEW4.07%$15M85.0K
3HCAHCA HEALTHCARE INChistory →COM2.61%$10M25.0K
4MCKMCKESSON CORPhistory →COM2.59%$10M13.0K
5UHSUNIV HEALTH SVChistory →CLASS B2.59%$10M52.5K
6BSXBOSTON SCIENTIFIC CORPORATIONhistory →COM2.34%$9M80.0K
7LLYELI LILLY & COhistory →COM2.33%$9M11.0K
8DHRDANAHER CORPhistory →COM2.15%$8M40.0K
9CAHCARDINAL HEALTHhistory →COM2.06%$8M45.0K
10SYKSTRYKER CORPhistory →COM2.04%$8M19.0K
11CORCENCORA INChistory →COM2.04%$7M25.0K
12ISRGINTUITIVE SURGhistory →COM NEW1.92%$7M13.0K
13MDTMEDTRONIC INChistory →SHS1.90%$7M80.0K
14NVONOVO-NORDISK A/Shistory →ADR1.88%$7M100.0K
15HUMHUMANA INC.history →COM1.80%$7M27.0K
16WATWATERS CORPhistory →COM1.71%$6M18.0K
17GILDGILEAD SCIENCES INChistory →COM1.51%$6M50.0K
18CICIGNA GROUP/THEhistory →COM1.48%$5M16.5K
19ABTABBOTT LABShistory →COM1.45%$5M39.2K
20AAGILENT TECHNOLOGIES INChistory →COM1.44%$5M45.0K
21UNHUNITEDHEALTH GRPhistory →COM1.27%$5M15.0K
22S24SELECT MEDICAL HOLDINGS CORPhistory →COM1.24%$5M300.0K
23DGXQUEST DIAGNOSTIC INChistory →COM1.22%$4M25.0K
24RVTYREVVITY INChistory →COM1.18%$4M45.0K
25BIOBIO-RAD LABS Ahistory →CL A1.18%$4M18.0K
26SNNSMITH & NEPHEWhistory →SPDN ADR NEW1.17%$4M140.0K
27RGENREPLIGEN CORPhistory →COM1.02%$4M30.0K
28WSTWEST PHARMACEUTICAL SERVICES INCCOM0.89%$3M15.0K
29EHCENCOMPASS HEALTH CORPCOM0.83%$3M25.0K
30AVTRAVANTOR INCCOM0.82%$3M225.0K
31ALGNALIGN TECH INCCOM0.77%$3M15.0K
32SGRYSURGERY PARTNERS INCCOM0.76%$3M125.0K
33BAXBAXTER INTERNATIONAL INC.COM0.62%$2M75.0K
34COOCOOPER COS INCCOM0.58%$2M30.0K
35ALNYALNYLAM PHARMACEUTICALSCOM0.58%$2M6.5K
36MDGLMADRIGAL PHARMACEUTICALS INCCOM0.41%$2M5.0K
37ARGXARGEN SE - ADRSPONSORED ADR0.37%$1M2.5K
38INSPINSPIRE MEDICAL SYSTEMS INCCOM0.35%$1M10.0K

Filing History

QuarterReported ValuePositionsFiledTypeLinks
Q1 2026$132M34Apr 15, 202613F-HRchanges · EDGAR ↗
Q4 2025$345M49Jan 21, 202613F-HRchanges · EDGAR ↗
Q3 2025$344M44Oct 23, 202513F-HRchanges · EDGAR ↗
Q2 2025$368M46Jul 25, 202513F-HRchanges · EDGAR ↗
Q1 2025$185M31Apr 22, 202513F-HRchanges · EDGAR ↗
Q4 2024$190M38Jan 23, 202513F-HRchanges · EDGAR ↗
Q3 2024$236M35Nov 6, 202413F-HRchanges · EDGAR ↗
Q2 2024$278M38Jul 29, 202413F-HRchanges · EDGAR ↗
Q1 2024$427M47May 1, 202413F-HRchanges · EDGAR ↗
Q4 2023$239M39Feb 5, 202413F-HRchanges · EDGAR ↗
Q3 2023$198M33Nov 7, 202313F-HRchanges · EDGAR ↗
Q2 2023$428M43Aug 9, 202313F-HRchanges · EDGAR ↗
Q1 2023$233M40May 8, 202313F-HRchanges · EDGAR ↗
Q4 2022$213M39Feb 8, 202313F-HRchanges · EDGAR ↗
Q3 2022$180M41Nov 4, 202213F-HRchanges · EDGAR ↗
Q2 2022$176M38Aug 10, 202213F-HRchanges · EDGAR ↗
Q1 2022$242M49May 9, 202213F-HRchanges · EDGAR ↗
Q4 2021$233M45Feb 8, 202213F-HRchanges · EDGAR ↗
Q3 2021$419M43Nov 12, 202113F-HRchanges · EDGAR ↗
Q2 2021$512M49Aug 10, 202113F-HRchanges · EDGAR ↗
Q1 2021$274M47May 12, 202113F-HRchanges · EDGAR ↗
Q4 2020$245M38Feb 16, 202113F-HRchanges · EDGAR ↗
Q3 2020$232M38Nov 13, 202013F-HRchanges · EDGAR ↗
Q2 2020$302M52Aug 14, 202013F-HRchanges · EDGAR ↗
Q1 2020$253M40May 15, 202013F-HRchanges · EDGAR ↗
Q4 2019$269M50Feb 13, 202013F-HRchanges · EDGAR ↗
Q3 2019$198M45Nov 12, 201913F-HRchanges · EDGAR ↗
Q2 2019$414M62Aug 14, 201913F-HRchanges · EDGAR ↗
Q1 2019$271M61May 8, 201913F-HRchanges · EDGAR ↗
Q4 2018$186M48Feb 12, 201913F-HRchanges · EDGAR ↗

13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.